The correlation between rheumatoid factor and anti cyclic citrullinated peptides with gene expression of FoxP3 in rheumatoid artheritis patients

Document Type: Original Article

Authors

1 Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah,Iran

2 Department of Epidemiology and Biostatistics, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah,Iran

3 Departmen of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran/Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran

4 Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

Abstract

Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affect 1-2% of people worldwide. Inflammation is an important factor in the pathogenesis of RA. Anti- Cyclic Citrullinated Peptid (Anti-CCP) antibody and Rheumatoid Factor (RF) are autoantibodies that promotes inflammatory reactions and have a crucial role in RA pathogenesis. Treg cells are necessary for the maintenance of immune homeostasis and prevention of autoimmunity. FoxP3 is essential transcription factor for development of these regulatory cells. In this study, we surveyed the effects of FoxP3 gene expression in peripheral blood on plasma levels of Anti-CCP and RF.
Methods: Peripheral blood samples were collected from 47 patients and 44 healthy subjects. Then plasma levels of Anti-CCP have been evaluated using ELISA method. Also RF was detected with latex agglutination test, and gene expression of FoxP3 analyzed by real time PCR .
Results: The amount of Anti-CCP and RF were significantly higher in our patients in comparison with healthy subjects (P<0.001) and (P< 0.001) respectively. Also significant reverse correlation between RF and Anti-CCP with gene expression of FoxP3 have been shown in our study (r: -0.630, r: -0.584) respectivly. The sensitivity and specificity of Anti-CCP and RF was (89.1%, 86.95%) and (91.3%, 91.1%) respectively for the diagnosis of RA.
Conclusion: Our data illustrated that FoxP3 gene expression have reverse significant correlation with plasma concentration of anti-CCP and RF.

Graphical Abstract

The correlation between rheumatoid factor and anti cyclic citrullinated peptides with gene expression of FoxP3 in rheumatoid artheritis patients

Keywords


1 .Allegri G, Costa CV, Ragazzi E, Steinhart H, Laresio L. Developments in tryptophan and serotonin metabolism. New york: Springer Science & Business Media; 2012. Doi: 10.1007/978-1-4615-0135-0

2.Arshadi D, Nikbin B, Shakiba Y, Kiani A, Jamshidi AR, Boroushaki MT. Plasma level of neopterin as amarker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody. Intimmunopharmacol. 2013;17(3):763-767. doi: 10.1016/j.intimp.2013.08.022.

3.Azevedo ARP, de Sousa HML, Monteiro JAF, Lima ARNP. Future perspectives of smartphone applications for rheumatic diseases self-management. Rheumatol Int. 2015;35(3):419-431. doi: 10.1007/s00296-014-3117-9

4 .Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785-797. doi: 10.1038/ni.1923

5. Jang E, Cho WS, Cho M-L, Park H-J, Oh H-J, Kang SM, et al. Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J Immunol. 2011;186(3):1546-1553.  doi: 10.4049/jimmunol.1002942

6.LeipeJ, Skapenko A, Lipsky PE, Schulze-Koops H. Regulatory T cells in rheumatoid arthritis. Arthritis Res Ther. 2005;7(3):93. doi: 10.1186/ar1718

7.Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med. 2004;200(3):277-285. doi:  10.1084/jem.20040165

8. Wing JB, Sakaguchi S. Foxp3+ Treg cells in humoral immunity. Int Immunol. 2013;26(2):61-69. doi: 10.1093/intimm/dxt060

9. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011;17(8):983-988. doi:10.1038/nm.2426

10 .Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, et al. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol. 2006;33(12):2390-2397. doi: 10.1007/s10067-008-1035-5

11.Niewold TB, Harrison M, Paget S. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. J Assoc Physic. 2007;100(4):193-201. doi: 10.1093/qjmed/hcm015

12 .Zendman A, Van Venrooij W, Pruijn G. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology. 2005;45(1):20-25. doi: 10.1093/rheumatology/kei111

13. Song Y, Kang E. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM: Int J Med. 2009;103(3):139-146. doi: 10.1093/qjmed/hcp165

14. Wing JB, Ise W, Kurosaki T, Sakaguchi S. Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4. Immunity. 2014;41(6):1013-1025. doi: 10.1016/j.immuni.2014.12.006

15. Sun H, Gao W, Pan W, Zhang Q, Wang G, Feng D, et al. Tim3+ Foxp3+ Treg Cells Are Potent Inhibitors of Effector T Cells and Are Suppressed in Rheumatoid Arthritis. Inflammation. 2017:1-9. doi: 10.1007/s10753-017-0577-6

16.Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008. Isr Med Assoc J. 2008;10(1):13.

17.Duarte J, Agua-Doce A, Oliveira VG, Fonseca JE, Graca L. Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice. PloS one. 2010;5(5):e10558. doi: 10.1371/journal.pone.0010558

18.Han GM, O’Neil-Andersen NJ, Zurier RB, Lawrence DA. CD4+ CD25 high Tcell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol. 2008;253(1):92-101. doi: 10.1186/ar4545

19 .Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, et al. Decreased FOXP3 levels in multiple sclerosispatients. J Neurosci Res. 2005;81(1):45-52. doi:10.1002/jnr.20522

20.Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-[alpha] in rheumatoid arthritis. Nat Med. 2013;19(3):322-328. doi: 10.1038/nm.3085